Mar 11, 2019, 09:51 AM by Michael Croft

MOUNTAIN VIEW, CA, UNITED STATES - Mar 11, 2019 - DNAnexus, Inc., the leader in biomedical informatics and data management, today announced the addition of an innovative browser for clinico-genomic cohorts to its DNAnexus Apollo™ Platform, allowing for easy at-scale navigation and exploration on combined genotypic and phenotypic data

Mar 11, 2019, 08:38 AM by Michael Croft

BERKELEY, CA, UNITED STATES - Mar 11, 2019 - Lygos, Inc., a full-stack producer of specialty chemicals that deliver high-value performance without the environmental toxicity, today announced three innovation research grants totaling $750,000 of non-equity funding to support advanced research and development

Mar 7, 2019, 14:55 PM by Michael Croft

Mar 7, 2019, 11:38 AM by Michael Croft

SAN JOSE, CA, UNITED STATES - Mar 7, 2019 - MGI, a subsidiary of BGI Group, unveiled its novel CoolNGS chemistry, a disruptive new sequencing approach for its DNBseq™ sequencing technology that enhances the throughput, accuracy, read length and cost effectiveness of DNA sequencing

Mar 7, 2019, 09:14 AM by Michael Croft

PHILADELPHIA, PA, UNITED STATES - Mar 7, 2019 - CRF Bracket today announced that Susie Robinson will join the company as Chief People Officer. Susie brings to CRF Bracket more than two decades of human resources leadership with an impressive track record of success as a global HR executive

Mar 7, 2019, 04:32 AM by Michael Croft

, MA - Mar 7, 2019 - North Reading, Mass. (March 5, 2019)-TraceLink Inc., the world's largest integrated digital supply network providing real-time information sharing for better patient outcomes, today announced Smart Inventory Tracker, a cloud-based end-to-end warehouse compliance solution offered within its integrated digital supply network

Mar 7, 2019, 03:40 AM by Michael Croft

BOSTON, MA, UNITED STATES - Mar 7, 2019 - The Pistoia Alliance, a global not-for-profit that works to lower barriers to innovation in life sciences R&D, today released proof of concept (PoC) software to enable the digitisation of analytical method descriptions, as part of its Method Database (MethodDB) project

Mar 6, 2019, 10:15 AM by Michael Croft

Bio-IT World  The latest genetic map published by Reykjavík, Iceland-based deCODE Genetics may well be the last, according to CEO and founder Kári Stefánsson. The high-resolution map of human recombination—which uses whole-genome sequence (WGS) data on nearly 130,000 people—is about as good as it can theoretically get, he says.

Mar 6, 2019, 08:11 AM by Michael Croft

WESTBURY, NY - Mar 6, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the launch of its XPRESSWAY Profile Safety Package, a compendium of 46 gene expression profiles for genes known to play pivotal roles in drug safety assessments

Mar 6, 2019, 07:47 AM by Michael Croft

LONDON, UNITED KINGDOM - Mar 6, 2019 - Following the successful conclusion of a pilot study, Clinithink's CLiX software is now being used by the Newcastle upon Tyne Hospitals NHS Foundation Trust - one of the UK's leading clinical research centres - to improve patient recruitment in their clinical trialsx

Mar 6, 2019, 05:51 AM by Michael Croft

- Mar 6, 2019 - British company Optibiotix has signed an exclusive manufacturing and supply agreement with Indian Healthcare company Zeon for the use of OptiBiotix’s science-based weight management technology, SlimBiome®

Mar 5, 2019, 10:46 AM by Michael Croft

HUNTINGDON VALLEY, PA, UNITED STATES - Mar 5, 2019 -   Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, announced today that it will introduce a new semi-automated assay workflow utilizing the CELLSEARCH® and DEPArrayTM platforms to enumerate and characterize circulating multiple myeloma cells (CMMC) from peripheral blood samples

Mar 5, 2019, 10:14 AM by Michael Croft

PRINCETON, NJ - Mar 5, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that the US Centers for Disease Control & Prevention (CDC) has awarded it a contract to strengthen the Agency’s death investigation and surveillance systems

Mar 5, 2019, 05:04 AM by Michael Croft

STEVENAGE, UK - Mar 5, 2019 - Procarta Biosystems, a privately held UK-based biotech company, today announced €1.5m of new funding from the Novo Holdings REPAIR Impact Fund to support development of novel therapies to combat antimicrobial resistance (AMR)

Mar 4, 2019, 01:19 AM by Michael Croft

SHIRLEY, NY - Mar 4, 2019 - BOC Sciences, a US-based global manufacturer of high-quality chemicals and efficient custom services to support the pharmaceutical industry through all stages of drug discovery, has recently added intermediates synthesis to its API synthesis portfolio

Mar 1, 2019, 14:50 PM by Michael Croft

SAN DIEGO, CA - Mar 1, 2019 - BINDING SITE'sImmunologicals Group is pleased to announce the addition of three (3) new native Bordetella pertussis antigens to its broad offering of products for in-vitro diagnostic (IVD) manufacturing and research applications

Mar 1, 2019, 09:44 AM by Michael Croft

- Mar 1, 2019 - Recipharm, the contract development and manufacturing organisation (CDMO), has achieved the new ISO 45001 certification at its Wasserburg facility in Germany

Feb 28, 2019, 05:09 AM by Michael Croft

SHIRLEY, NY - Feb 20, 2019 - As a leading service provider that focuses on vaccines fields, Creative Biolabs now releases comprehensive one-stop vaccine development services to help researchers and vaccine companies to reduce the cost of failure and increase the chance of clinical success

Feb 28, 2019, 04:03 AM by Michael Croft

, NY - Feb 28, 2019 - Rare Disease Day - A unique non-profit and private partnership using a datathon and an AI-powered technology platform has identified five repurposable drug candidates to treat a painful chronic disease affecting about a million people globally and for which there is no current treatment

Feb 27, 2019, 13:45 PM by Michael Croft

DURHAM, NC - Feb 27, 2019 - TARGET PharmaSolutions, Inc., a real-world clinical data solutions company, is pleased to announce that Novartis Pharma AG is the first industry partner to provide multi-year support to TARGET-DERM registry TARGET-DERM is a global longitudinal observational study that evaluates adult and pediatric patients with immune-mediated inflammatory skin conditions (IMISCs)